Metraipolis › archive › dc_257ea83032b9
A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China… — Europe PMC PMID:41570001
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41570001
- DOI
- 10.1371/journal.pone.0341154
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T13:36:55.996Z
- SHA-256 of the archived text
41d821c67167ca305ced5344976f256dbbc1425ac2c2c46018ddb226269477c8- Stable URL of this page
https://metraipolis.com/documento/dc_257ea83032b9
How to cite
A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China… — Europe PMC PMID:41570001 — Europe PMC (en), https://europepmc.org/article/MED/41570001 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_257ea83032b9 (Metraipolis archive dc_257ea83032b9, sha256 41d821c67167ca305ced5344976f256dbbc1425ac2c2c46018ddb226269477c8)
BibTeX
@misc{dc257ea83032b9,
title = {A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China… — Europe PMC PMID:41570001},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41570001},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_257ea83032b9; sha256 41d821c67167ca305ced5344976f256dbbc1425ac2c2c46018ddb226269477c8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41570001. Agents can read the archived copy with the MCP tool read_document.